Minimally Invasive Procedures Combined with Better Imaging Technologies Boosts Angioplasty and VCD Markets - U.S. Angioplasty and Vascular Closure Devices Markets

Business Wire, Dec 7, 2006

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c46634) has announced the addition of U.S. Angioplasty and Vascular Closure Devices Markets to their offering.

This Frost & Sullivan research service titled U.S. Angioplasty and Vascular Closure Devices Markets provides a detailed analysis market drivers, restraints, and trends that are impacting the angioplasty and vascular closure devices markets. This analysis is available through our Medical Devices Growth Partnership Service program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data as well as many interactive features including Analyst Inquiry Time and Client Councils.

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction.

The foundation of Frost & Sullivan's GPS includes:

-Assisting companies to reach their full potential in the core business

-Providing growth strategies to help companies expand into related businesses

-Preemptively redefining the core business during market turbulence

-Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies

-Recommending growth management strategies through continuous partnership

Content Outline:

1. Executive Summary

2. Total Angioplasty and Vascular Closure Devices Market

3 Competitive Analysis

4. Vascular Closure Devices

5. Appendix

Increasing Desire to Improve Patient's Quality of Life and Growing Numbers of Patients Drive VCD Markets

The interventional cardiology market is a highly technology driven market and has been subjected to massive technological growth over the past 30 years. The angioplasty balloon catheter market has been considerably lucrative, targeting treatment of both coronary and peripheral vascular diseases. So far there has been no breakthrough in technology that has been able displace angioplasty balloon catheters in spite of its limitations. "Vascular closure device (VCD) technology, a comparatively new technology, has drafted new vistas to drive interventional surgery a step further," according to the analyst of the study. "Both angioplasty balloon catheters and VCDs are technologically propelled and the main focus of these approaches has been to improve patient's quality of life."

A very obvious but undeniable fact that drives this market is the aging population in the United States. Cardiovascular disease is the largest life threatening disease in the United States since 1900. In 2003, about 71.3 million people were affected by cardiovascular diseases. Both angioplasty and VCD play important roles in addressing solutions for coronary artery and peripheral vascular diseases. According to a 2003 publication, about 13.2 million have been affected by coronary artery disease and about 8 to 12 million are affected by peripheral vascular disease in the United States.

Minimally Invasive Procedures combined with Better Imaging Technologies Boosts Angioplasty and VCD Markets

Angioplasty, being a minimally invasive interventional procedure, offers certain benefits when compared with highly-invasive surgeries. It offers a reduced risk of infection and less pain and trauma, thereby enhancing patient comfort. The overall procedure cost is also comparatively lower than highly invasive surgeries. The reduced recovery period helps minimize hospitalization costs. The fact that patients are able to get back to their routine much sooner is also another major advantage.

Angioplasty, coupled with stenting and other pharmacological agents, has been observed to reduce restenosis. Overall, these developments augment the success of the interventional procedure. Currently, digitalized cath-labs have also revolutionized the way interventional practitioners look at the organ or vessel. Developments in imaging technology also include improved contrast with lower doses of radiation and enhanced resolution. "The introduction of intravascular ultrasound enables precise navigation of the balloon catheter through the vasculature and ensures more accurate placement of stents," explains the analyst. "Additionally, they also aid in accomplishing proper dilation of the artery and in characterizing the plaque which results in higher success rates which in turn boosts patients' confidence in the procedure."

For more information visit http://www.researchandmarkets.com/reports/c46634

Source: Frost & Sullivan